Marco Lenzi

17.8k total citations · 5 hit papers
153 papers, 12.3k citations indexed

About

Marco Lenzi is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Marco Lenzi has authored 153 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Hepatology, 97 papers in Epidemiology and 25 papers in Rheumatology. Recurrent topics in Marco Lenzi's work include Liver Disease Diagnosis and Treatment (89 papers), Liver Diseases and Immunity (84 papers) and Hepatitis C virus research (56 papers). Marco Lenzi is often cited by papers focused on Liver Disease Diagnosis and Treatment (89 papers), Liver Diseases and Immunity (84 papers) and Hepatitis C virus research (56 papers). Marco Lenzi collaborates with scholars based in Italy, United Kingdom and United States. Marco Lenzi's co-authors include Giulio Marchesini, Elisabetta Bugianesi, Nazario Melchionda, Stefania Natale, Gabriele Forlani, Luigi Muratori, Francesco B. Bianchi, F. Cassani, Giampaolo Bianchi and Mara Brizi and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Marco Lenzi

147 papers receiving 12.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The NAFLD fibrosis score

2007 2.3k citations Giulio Marchesini, Marco Lenzi et al. Hepatology profile →
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome

2003 2.1k citations Giulio Marchesini, Elisabetta Bugianesi et al. Hepatology profile →
Nonalcoholic Fatty Liver Disease

2001 2.1k citations Giulio Marchesini, Giampaolo Bianchi et al. profile →
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

2016 653 citations Fabio Conti, F. Buonfiglioli et al. profile →
Diagnosis and management of autoimmune hepatitis

2023 112 citations Luigi Muratori, Ansgar W. Lohse et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Marco Lenzi	9.9k	6.8k	3.1k	2.0k	1.5k	153	12.3k
Silvia Fargion	7.3k 0.7×	3.1k 0.5×	2.9k 1.0×	1.1k 0.6×	852 0.6×	267	11.6k
Anna Ludovica Fracanzani	6.2k 0.6×	2.6k 0.4×	2.5k 0.8×	1.1k 0.5×	687 0.5×	217	9.4k
Paola Dongiovanni	6.5k 0.7×	2.2k 0.3×	2.8k 0.9×	1.1k 0.5×	403 0.3×	188	9.1k
Per Stål	6.0k 0.6×	3.6k 0.5×	2.2k 0.7×	948 0.5×	175 0.1×	135	7.7k
Sven Francque	7.3k 0.7×	3.2k 0.5×	2.9k 0.9×	1.5k 0.7×	132 0.1×	194	9.1k
Cynthia D. Guy	5.5k 0.6×	2.3k 0.3×	2.2k 0.7×	1.2k 0.6×	152 0.1×	104	7.7k
Paolo Geñtilini	5.3k 0.5×	6.9k 1.0×	361 0.1×	2.4k 1.2×	480 0.3×	170	9.6k
Marcello Persico	4.3k 0.4×	3.3k 0.5×	987 0.3×	803 0.4×	262 0.2×	204	6.5k
Henning Grønbæk	5.2k 0.5×	2.3k 0.3×	1.4k 0.5×	1.6k 0.8×	133 0.1×	329	8.4k
Christopher L. Bowlus	4.0k 0.4×	4.9k 0.7×	1.1k 0.4×	3.2k 1.6×	593 0.4×	231	8.9k

Countries citing papers authored by Marco Lenzi

Since Specialization

Citations

This map shows the geographic impact of Marco Lenzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Lenzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Lenzi more than expected).

Fields of papers citing papers by Marco Lenzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Lenzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Lenzi. The network helps show where Marco Lenzi may publish in the future.

Co-authorship network of co-authors of Marco Lenzi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Lenzi. A scholar is included among the top collaborators of Marco Lenzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Lenzi. Marco Lenzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Granito, Alessandro, Paolo Muratori, Γεώργιος Παππάς, et al.. (2024). Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells. Clinical & Experimental Immunology. 217(3). 233–239. 1 indexed citations

Lalanne, Claudine, Chiara Quarneti, Chiara Ricci, et al.. (2022). Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 7 indexed citations

Balato, Marco, Carlo Petrarca, Marco Lenzi, et al.. (2021). On the Necessity of a Customized Knee Spacer in Peri-Prosthetic Joint Infection Treatment: 3D Numerical Simulation Results. Journal of Personalized Medicine. 11(10). 1039–1039. 4 indexed citations

Muratori, Paolo, Alessandro Granito, Marco Lenzi, & Luigi Muratori. (2021). Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset. Liver International. 41(3). 529–534. 12 indexed citations

Granito, Alessandro, Chiara Ricci, Luigi Muratori, et al.. (2021). Decompensated Cirrhosis as Presentation of LKM1/LC1 Positive Type 2 Autoimmune Hepatitis in Adulthood. A Rare Clinical Entity of Difficult Management. SHILAP Revista de lepidopterología. 12(1). 67–75. 4 indexed citations

Casadei‐Gardini, Andrea, Francesco Giuseppe Foschi, Fabio Conti, et al.. (2018). Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. Digestive and Liver Disease. 51(5). 681–688. 47 indexed citations

Lenzi, Marco, et al.. (2017). Hydrogen production from biomass: The behavior of impurities over a CO shift unit and a biodiesel scrubber used as a gas treatment stage. Korean Journal of Chemical Engineering. 34(8). 2198–2203. 22 indexed citations

Liberal, Rodrigo, Ynto S. de Boer, Raúl J. Andrade, et al.. (2016). Expert clinical management of autoimmune hepatitis in the real world. Alimentary Pharmacology & Therapeutics. 45(5). 723–732. 60 indexed citations

Muratori, Paolo, Alessandro Granito, Γεώργιος Παππάς, et al.. (2009). The Serological Profile of the Autoimmune Hepatitis/Primary Biliary Cirrhosis Overlap Syndrome. The American Journal of Gastroenterology. 104(6). 1420–1425. 73 indexed citations

10.

Lenzi, Marco. (2007). Moderatismo e amministrazione nel Granducato di Toscana : la carriera di Luigi Serristori. 3–255.

11.

Re, Vallì De, Laura Caggiari, Maria Paola Simula, et al.. (2007). Role of the HLA Class II. Annals of the New York Academy of Sciences. 1107(1). 308–318. 13 indexed citations

12.

Guidi, M., Paolo Muratori, Alessandro Granito, et al.. (2005). Hepatic steatosis in chronic hepatitis C: impact on response to anti‐viral treatment with peg‐interferon and ribavirin. Alimentary Pharmacology & Therapeutics. 22(10). 943–949. 9 indexed citations

13.

Marchesini, Giulio, Elisabetta Bugianesi, Gabriele Forlani, et al.. (2003). Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome. Hepatology. 37(4). 917–923. 2144 indexed citations breakdown →

14.

Ma, Yun, Mark Thomas, Manabu Okamoto, et al.. (2002). Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the Molecule. The Journal of Immunology. 169(1). 277–285. 64 indexed citations

15.

Lenzi, Marco, Stefano Bellentani, Gioconda Saccoccio, et al.. (1999). Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut. 45(3). 435–441. 140 indexed citations

16.

Cassani, F., Michela Cataleta, Pier Paolo Valentini, et al.. (1997). Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile. Hepatology. 26(3). 561–566. 193 indexed citations

17.

Lenzi, Marco, et al.. (1996). Dermatite infectiva associada ao htlv-1 : relato de caso. Anais Brasileiros de Dermatologia. 71(2). 115–118. 12 indexed citations

18.

Muratori, Luigi, Marco Lenzi, Yuanfang Ma, et al.. (1995). Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.. Gut. 37(3). 406–412. 69 indexed citations

19.

Lenzi, Marco, Luigi Muratori, Michela Cataleta, et al.. (1995). Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.. Gut. 36(5). 749–754. 63 indexed citations

20.

Ma, Yuanchen, Marco Lenzi, Joop Gäken, et al.. (1992). 32 THE TARGET ANTIGEN OF LIVER KIDNEY MICROSOMAL ANTIBODY IS DIFFERENT IN TYPE II AUTOIMMUNE CHRONIC ACTIVE HEPATITIS AND CHRONIC HEPATITIS C VIRUS INFECTION. Journal of Pediatric Gastroenterology and Nutrition. 15(3). 346–346. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact